Clinical Trial Update: Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) [NA]

View source ↗

Summary

The LIVELONG trial from University of California, Davis is an ongoing study evaluating locally ablative therapy for oligoprogressive gastrointestinal cancers an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendiceal Cancer
• Colorectal Cancer
• Esophageal Cancer
• Extrahepatic Cholangiocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Intrahepatic Cholangiocarcinoma
• Small Intestine Cancer

Snippet

Sponsor: University of California, Davis | Conditions: Esophageal Cancer, Small Bowel Cancer | NA | Status: RECRUITING